Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7231 p50
11 January 2003

This page
Reprint
Photocopy

   

PDF* 75K

Letters

  Period-of-treatment fee
  PI insurance
  Insulin labelling
  The Register
  Council elections
  The Society
  The Journal
  Christmas miscellany


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

PI insurance

How many civil claims?

From Mr J. Sharp, HonMRPharmS

That Mark Koziol (PJ, 14 December 2002, p844) should be a staunch advocate of personal indemnity insurance is entirely unsurprising. He is a director of a company that sells insurance of this type.

What might well cause the raising of the odd quizzical eyebrow is his assertion that "the vast majority of civil claims against pharmacists are settled out of court".

A proposition in these terms strongly implies that there is a considerable total number of civil claims made against pharmacists, for it would be distinctly absurd, say, to refer to two out of three as a "vast majority".

Perhaps Mr Koziol could tell us the number of civil claims made against pharmacists per year, and what, exactly, is that "vast majority"?

John Sharp
Woodley, Berkshire

 

MARK KOZIOL, director, The Pharmacy Insurance Agency, replies:

The Pharmacy Insurance Agency is only one of the pharmacy defence organisations and I will therefore have knowledge of only a proportion of the whole. Furthermore it can take some years before a final outcome on an incident becomes apparent. Additionally, approximately 50 per cent of error incidents that initially look like they will result in a civil claim never do so because insured persons act promptly on advice given to them by their defence organisation and take proactive measures to minimise the chances of an incident going any further.

However, subject to those considerations I can confirm that in 2000, I am aware of 164 incidents that did lead to civil claims being made against pharmacists, of which 148 were settled out of court; this by anyone's reckoning is a vast majority. Fortunately, there were no expensive landmark test cases fought in the courts that year, the largest claim being for just over £20,000 and half of that was settled by the prescriber's insurer. Despite that, by the time all the cases will have been finally settled it is estimated that the total cost of claims for that year will be well in excess of £200,000. There is still a small number of more complex cases outstanding from that year and as yet it is uncertain as to whether they will end up in court.

Risk management is all about anticipating errors or studying their causes once they occur and then making changes in practice so as to minimise the chances of their occurrence in the future. Pharmacists wishing to learn more about how to deal with an error once it has occurred or, ideally, how to help prevent one from occurring in the first place should consider attending one of the PIA risk management seminars which are usually held at local Royal Pharmaceutical Society branch or other meetings in various locations throughout the United Kingdom.

Send your letter to The Editor

Previous Topic (Period-of-treatment fee)
Next Topic (Insulin labelling)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal